|The full article is available to subscribers||Subscriber Login|
The FDA has approved Kyleena (Bayer), an intrauterine device (IUD) that releases the synthetic progestin levonorgestrel, for prevention of pregnancy. It is the fourth levonorgestrel-releasing IUD to be approved in the US. Like Mirena, which has been available since 2000, Kyleena is approved for up to 5 years of use.
IUDs — IUDs provide convenient, long-term contraception and a rapid return to fertility after removal; they are considered safe for use in most women, including adolescents and nulliparous women.1 All levonorgestrel-releasing IUDs, which are approved for 3 or 5 years of use, can reduce menstrual bleeding and dysmenorrhea. Amenorrhea can occur, especially with devices that contain more levonorgestrel.2 ParaGard T380A, a copper-containing IUD, is FDA-approved for up to 10 years... more
- KM Curtis and JF Peipert. Long-acting reversible contraception. N Engl J Med 2017; 376:461.
- Choice of contraceptives. Med Lett Drugs Ther 2015; 57:127.
- A new low-dose levonorgestrel-releasing IUD (Skyla). Med Lett Drugs Ther 2013; 55:21.
- Liletta – a third levonorgestrel-releasing IUD. Med Lett Drugs Ther 2015; 57:99.
- EN Berry-Bibee et al. The safety of intrauterine devices in breastfeeding women: a systematic review. Contraception 2016; 94:725.
- KM Curtis et al. U.S. selected practice recommendations for contraceptive use, 2016. MMWR Recomm Rep 2016; 65:1.